| Climedo Health GmbH. (3/20/24). "Press Release: Climedo Establishes Advisory Board to Enter its Next Growth Chapter". Munich. |
2024-03-20 |
| BioNTech SE. (3/20/24). "Press Release: BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer". Mainz. |
2024-03-20 |
| Capstan Therapeutics, Inc.. (3/20/24). "Press Release: Capstan Therapeutics Announces $175M Oversubscribed Series B Financing". San Diego, CA. |
2024-03-20 |
| FundaMental Pharma GmbH. (3/20/24). "Press Release: FundaMental Pharma Appoints Industry Veteran Dr. Lorenz Mayr as Non-Executive Director". Heidelberg. |
2024-03-20 |
| Idorsia Ltd.. (3/20/24). "Press Release: US FDA Approves Idorsia’s Once-daily Tryvio (aprocitentan) – the First and Only Endothelin Receptor Antagonist for the Treatment of High Blood Pressure Not Adequately Controlled in Combination with other Antihyper |
2024-03-20 |
| SolasCure Ltd.. (3/20/24). "Press Release: SolasCure Awarded £405K Innovate UK Biomedical Catalyst Grant to Advance Chronic Wound Care". Cambridge. |
2024-03-20 |
| Medios AG. (3/18/24). "Press Release: Medios Acquires Dutch Market Leader in Pharmaceutical Compounding Services". Berlin. |
2024-03-18 |
| Idorsia Ltd.. (3/18/24). "Press Release: Idorsia and Viatris Successfully Close the Transaction for the Global Research and Development Collaboration". Allschwil. |
2024-03-18 |
| Mission Therapeutics Ltd.. (3/14/24). "Press Release: Mission Therapeutics Raises £25.2 Million to Progress Clinical Candidates in the Area of Mitophagy". Cambridge. |
2024-03-14 |
| Alithea Genomics S.A.. (3/14/24). "Press Release: Alithea Genomics Closes CHF 2.8 Million in Seed Financing Extension Led by Novalis Biotech". Lausanne. |
2024-03-14 |
| IMBA – Institute of Molecular Biotechnology GmbH. (3/14/24). "Press Release: Elly Tanaka – IMBA’s New Scientific Director". |
2024-03-14 |
| Aignostics GmbH. (3/14/24). "Press Release: Bayer and Aignostics to Collaborate on Next Generation Precision Oncology". |
2024-03-14 |
| Asgard Therapeutics AB. (3/14/24). "Press Release: Asgard Therapeutics Announces €30 Million Series A Financing to Advance Its First-in-Class in vivo Cell Reprogramming Platform for Immuno-oncology". Lund. |
2024-03-14 |
| Tubulis GmbH. (3/14/24). "Press Release: Tubulis Closes Upsized €128 Million Series B2 to Accelerate Clinical Development of Solid Tumor-Focused ADC Pipeline". Munich. |
2024-03-14 |
| ERS Genomics Ltd.. (3/13/24). "Press Release: Ricoh and ERS Genomics Enter into CRISPR/Cas9 License Agreement". Tokyo & Dublin. |
2024-03-13 |
| CRISPR Therapeutics AG. (3/13/24). "Press Release: CRISPR Therapeutics Proposes New Appointment to the Board of Directors". Zug & Boston, MA. |
2024-03-13 |
| ProBioGen AG. (3/13/24). "Press Release: ProBioGen Partners with Mapp Biopharmaceutical, Inc. for Groundbreaking Development of Afucosylated Antibody against Marburg Virus Disease Using GlymaxX Technology". Berlin. |
2024-03-13 |
| IDRx, Inc.. (3/12/24). "Press Release: IDRx Strengthens Executive Team with Appointments of Tim Clackson, Ph.D., as CEO and Brad Dahms as CFO and CBO". Plymouth, MA. |
2024-03-12 |
| Mahana Therapeutics Inc.. (3/12/24). "Press Release: Mahana Therapeutics Acquires Cara Care to Become a Global Leader in the Digital Treatment of Chronic Conditions". San Francisco, CA. |
2024-03-12 |
| Sosei Group Corporation (d/b/a Sosei Heptares). (3/11/24). "Press Release: Boehringer Ingelheim and Sosei Heptares Join Forces to Develop First-in-class Treatments Targeting All Symptoms of Schizophrenia". Ingelheim, Tokyo & Cambridge. |
2024-03-11 |
| Praque.bio, z.s.. (3/11/24). "Press Release: This Fall Prague Will Be the Stage for a Showcase of Cutting-edge Biotechnologies Featuring Prominent Figures such as Christian A. Stein, Petr Jansa, and other Leading Experts". Prague. |
2024-03-11 |
| IZB Martinsried. (3/8/24). "Press Release: Christian Gnam Succeeds Dr. Peter Zobel as New Managing Director of the Biotechnology Innovation and Start-up Center (IZB)". Martinsried. |
2024-03-08 |
| ProteinDistillery GmbH. (3/7/24). "Press Release: ProteinDistillery Raises €15 Million in Seed Funding". Esslingen & Berlin. |
2024-03-07 |
| Traceless Materials GmbH. (3/7/24). "Press Release: Traceless Demo Plant Will Be Built in Hamburg-Harburg". Hamburg. |
2024-03-07 |
| Affimed N.V.. (3/6/24). "Press Release: Affimed Announces 1-for-10 Reverse Stock Split". Mannheim. |
2024-03-06 |
| Evotec SE. (3/6/24). "Press Release: Evotec and Claris Ventures Streamline Access to Accelerate Programmes from Claris's Portfolio Companies into the Clinic". Hamburg & Turin. |
2024-03-06 |
| Tubulis GmbH. (3/5/24). "Press Release: Tubulis to Present Preclinical Proof-of-Concept Data for Two Lead ADC Candidates Targeting Solid Tumors at the AACR Annual Meeting 2024". Munich. |
2024-03-05 |
| C4 Therapeutics, Inc.. (3/4/24). "Press Release: C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Germany, Against Critical Oncogenic Proteins". Watertown, MA. |
2024-03-04 |
| BRAIN Biotech AG. (2/29/24). "Press Release: BRAIN Biotech AG Successfully Placed EUR 5.0 Million Convertible Bond for the Financing of Further Growth Initiatives [Not for US, AU, et al.]". Zwingenberg. |
2024-02-29 |
| Symrise AG. (2/29/24). "Press Release: Dr Jean-Yves Parisot Assumes CEO Position from Dr Heinz-Jürgen Bertram". Holzminden. |
2024-02-29 |
| Royal Philips. (28/2/24). "Press Release: Charlotte Hanneman to Succeed Abhijit Bhattacharya as Philips’ Chief Financial Officer (CFO)". Amsterdam. |
2024-02-28 |
| Idorsia Ltd.. (2/28/24). "Press Release: Idorsia and Viatris Enter into a Significant Global Research and Development Collaboration". Allschwil. |
2024-02-28 |
| Centogene N.V.. (2/28/24). "Press Release: Centogene Explores Strategic Alternatives". Cambridge, MA, Rostock & Berlin. |
2024-02-28 |
| Centogene N.V.. (2/28/24). "Press Release: Centogene Announces Receipt of Nasdaq Notice of Delisting and Intention to Request a Hearing". Cambridge, MA, Rostock & Berlin. |
2024-02-28 |
| Miltenyi Biotec B.V. & Co. KG. (2/27/24). "Press Release: Miltenyi Biotec Opens Its First Office in India and Plans to Invest in First of Its Kind Cell and Gene Therapy Center of Excellence". Hyderabad. |
2024-02-27 |
| InflaRx N.V.. (2/22/24). "Press Release: InflaRx Appoints Jan Medina as Head of Investor Relations". Jena. |
2024-02-22 |
| Ansa Biotechnologies, Inc.. (2/22/24). "Press Release: Ansa Biotechnologies Appoints Jason T. Gammack as CEO and Prepares for Launch of Rapid Enzymatic Synthesis Service for Complex DNA Sequences". Emeryville, CA. |
2024-02-22 |
| Plasmion GmbH. (2/21/24). "Press Release: Plasmion and Waters Corporation Sign a Co-marketing and Co-promotion Agreement to Enhance and Simplify Chemical Analysis". Augsburg. |
2024-02-21 |
| Cyclize GmbH. (2/21/24). "Press Release: ClimateTech Startup Cyclize Secures €5 Million in Seed Funding for Revolutionary Plastic Recycling Technology". Munich. |
2024-02-21 |
| Omnix Medical Ltd.. (2/20/24). "Press Release: Omnix Medical Granted Fast-Track Designation by U.S. FDA for its Next-Generation Anti-Infective OMN6". Jerusalem. |
2024-02-20 |
| Evonik. (2/20/24). "Press Release: Evonik Partners with the University of Mainz to Commercialize a New Class of PEG Lipids for Nucleic Acid Delivery". Essen. |
2024-02-20 |
| Freenome, Inc.. (2/15/24). "Press Release: Freenome Raises $254 Million in New Funding to Accelerate its Platform for Early Cancer Detection". South San Francisco, CA. |
2024-02-15 |
| SAFIA Technologies GmbH. (2/15/24). "Press Release: Sysmex Partec and SAFIA Technologies. Pioneering Mycotoxin Analysis". Görlitz & Berlin. |
2024-02-15 |
| Firefly Bio, Inc.. (2/15/24). "Press Release: Firefly Bio Debuts with $94 Million Series A Financing". South San Francisco, CA. |
2024-02-15 |
| MTIP AG. (2/14/24). "Press Release: MTIP Invests $15 Million in Caresyntax". |
2024-02-14 |
| Earlybird VC Management GmbH & Co KG. (2/14/24). "Press Release: Earlybird Health Closes Fresh Fund of EUR 173m". Berlin & Cologne. |
2024-02-14 |
| VantAI. (2/13/24). "Press Release: VantAI Enters Collaboration With Bristol Myers Squibb to Accelerate Molecular Glue Drug Discovery Through Artificial Intelligence". New York, NY. |
2024-02-13 |
| CRISPR Therapeutics AG. (2/13/24). "Press Release: European Commission Approves First CRISPR/Cas9 Gene-Edited Therapy, Casgevy (exagamglogene autotemcel), for the Treatment of Sickle Cell Disease (SCD) and Transfusion-Dependent Beta Thalassemia (TDT)". Z |
2024-02-13 |
| Scinai Immunotherapeutics Ltd.. (2/13/24). "Press Release: Scinai Welcomes Liat Halpert as Head of Business Development and Sales". Jerusalem. |
2024-02-13 |
| PathAI Inc.. (2/13/24). "Press Release: PathAI Announces Exclusive Collaboration with Roche Tissue Diagnostics to Advance AI-enabled Interpretation for Companion Diagnostics". Boston, MA. |
2024-02-13 |
| CRISPR Therapeutics AG. (2/13/24). "Press Release: CRISPR Therapeutics Announces $280 Million Registered Direct Offering". Zug & Boston, MA. |
2024-02-13 |
| Amply Discovery Ltd.. (2/12/24). "Press Release: Amply Discovery Raises £1.4m in Innovate UK Grant Funding to Tackle Complex Diseases". |
2024-02-12 |
| Repare Therapeutics Inc.. (2/12/24). "Press Release: Repare Therapeutics to Regain Global Rights to Camonsertib". Cambridge, MA & Montréal. |
2024-02-12 |
| T-Curx GmbH. (2/9/24). "Press Release: T-Curx Extends Its Management Team with Marion Jung, PhD, as Its New Chief Operating Officer". |
2024-02-09 |
| Boehringer Ingelheim. (2/8/24). "Press Release: Boehringer Ingelheim and CBmed Join Forces to Translate Novel Cancer Therapy Approaches Faster into New Medicines for Patients". Ingelheim & Graz. |
2024-02-08 |
| Vandria S.A.. (2/8/24). "Press Release: Vandria Awarded €3.8M in Prestigious Innosuisse and Eurostars Grants to Advance Innovative Drug Programs for Age-Related Diseases of the CNS and Muscle". Lausanne. |
2024-02-08 |
| BioNTech SE. (2/8/24). "Press Release: BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs". Mainz & London. |
2024-02-08 |
| Zetta Genomics Ltd.. (2/8/24). "Press Release: Zetta Genomics Expands Second Seed Funding Round with Additional £1.8 Million". |
2024-02-08 |
| FyoniBio GmbH. (2/7/24). "Press Release: FyoniBio Collaborates with BioLamina and Alder Therapeutics". Berlin. |
2024-02-07 |
| VantAI. (2/7/24). "Press Release: VantAI Appoints Jae Won Kim as Chief Operating Officer and Chief Financial Officer". New York, NY. |
2024-02-07 |
| MorphoSys AG. (2/5/24). "Press Release: MorphoSys Enters into Business Combination Agreement to Be Acquired by Novartis for € 2.7 Billion Equity Value. Tafasitamab Sold to Incyte". Planegg. |
2024-02-05 |
| Silence Therapeutics plc. (2/5/24). "Press Release: Silence Therapeutics Announces Oversubscribed $120 Million Private Placement". London. |
2024-02-05 |
| Theryq. (2/2/24). "Press Release: Theryq and Gustave Roussy Have Been Selected as Part of the "i-Démo" France 2030 Call for Projects". Rousset. |
2024-02-02 |
| NLC Ventures Netherlands B.V.. (2/2/24). "Press Release: NLC Health Ventures and BioScience Valuation (BSV) Announce Strategic Collaboration". Amsterdam. |
2024-02-02 |
| ITM Isotope Technologies Munich SE. (2/1/24). "Press Release: ITM Obtains Manufacturing License in the U.S.". Garching & Princeton, NJ. |
2024-02-01 |
| NeoPhore Ltd.. (2/1/24). "Press Release: NeoPhore Raises an Additional £9.6m (USD $12.2m) Series B Financing Extension to Further Progress Drug Discovery Pipeline". London. |
2024-02-01 |
| Praque.bio, z.s.. (2/1/24). "Press Release: Petra Kinzlova Became the New Director of the Prague.bio Cluster". Prague. |
2024-02-01 |
| BioNTech SE. (1/31/24). "Press Release: BioNTech and DualityBio Receive FDA Fast Track Designation for Next-Generation Antibody-Drug Conjugate Candidate BNT325/DB-1305". Mainz & Shanghai. |
2024-01-31 |
| ITM Isotope Technologies Munich SE. (1/30/24). "Press Release: ITM and Alpha-9 Oncology Announce Global Supply Agreement to Support Alpha-9’s Clinical Radiopharmaceutical Development Program". Garching & Vancouver, BC. |
2024-01-30 |
| Enterprise Therapeutics Ltd.. (1/30/24). "Press Release: Enterprise Therapeutics Closes £26 million ($33.1 million) Series B Follow-on Financing". Brighton. |
2024-01-30 |
| Aion Labs. (1/30/24). "Press Release: Aion Labs Launches New Startup Leveraging Machine Learning for Molecular Glue Discovery". Rehovot. |
2024-01-30 |
| Novonesis. (1/29/24). "Press Release: The Combination of Novozymes and Chr. Hansen Is Now Successfully Completed, Creating Novonesis – a Leading Global Biosolutions Partner". Copenhagen. |
2024-01-29 |
| Merck KGaA. (1/29/24). "Press Release: Merck Establishes First Digital Hub in Singapore". Singapore. |
2024-01-29 |
| Hookipa Pharma Inc.. (1/29/24). "Press Release: Hookipa Pharma Provides Update on Business Priorities and Oncology Partnership Programs". New York, NY & Vienna. |
2024-01-29 |
| Affluent Medical S.A.. (1/29/24). "Press Release: Affluent Medical Closes €3.5 Million Bridge via Capital Iincrease from Key Shareholders [not for US, CA, AU, or JP]". Aix-en-Provence. |
2024-01-29 |
| Formycon AG. (1/29/24). "Press Release: Gedeon Richter Becomes Strategic Investor of Formycon via Equity Investment". Munich & Budapest. |
2024-01-29 |
| Kadans Science Partner. (1/29/24). "Press Release: Kadans Becomes New Partner for Rheinland-Pfalz Location – Collaboration with Technologiezentrum Mainz". |
2024-01-29 |
| Green Elephant Biotech GmbH. (1/29/24). "Press Release (Blog Post): Product Launch. Green Elephant Biotech Launches the World's First Plant-based 96-well Plate". |
2024-01-29 |
| SGS S.A.. (1/26/24). "Press Release: SGS 2023 Full Year Results and Strategic Update". |
2024-01-26 |
| SGS S.A.. (1/26/24). "Press Release: Géraldine Picaud to Succeed Frankie Ng as Chief Executive Officer". |
2024-01-26 |
| Repare Therapeutics Inc.. (1/25/24). "Press Release: Repare Therapeutics Announces Achievement of $40 Million Roche Clinical Milestone Payment". Cambridge, MA & Montréal. |
2024-01-25 |
| Bruker Corporation. (1/25/24). "Press Release: Bruker Announces Agreement to Acquire Chemspeed". Basel. |
2024-01-25 |
| InflaRx N.V.. (1/25/24). "Press Release: InflaRx Announces Initiation of Its Commitment Program for GOHIBIC (vilobelimab) to Help Broaden Access for Eligible Patients". Ann Arbor, MI. |
2024-01-25 |
| IMU Biosciences (Melio Health UK Ltd.). (1/24/24). "Press Release: IMU Biosciences Secures £11.5 Million in Series A Funding to Revolutionise Immune Powered Precision Medicine". London. |
2024-01-24 |
| BenevolentAI Ltd.. (1/24/24). "Press Release: BenevolentAI Appoints Dr. Joerg Moeller as Chief Executive Officer". London. |
2024-01-24 |
| BioLizard N.V.. (1/23/24). "Press Release: BioLizard Opens Office in Switzerland – AI-powered Digital Transformation of Life Sciences at Biopôle in Lausanne". Lausanne & Ghent. |
2024-01-23 |
| Bruker Corporation. (1/23/24). "Press Release: Biognosys Expands US Footprint with New Proteomics CRO Facility in Massachusetts". Zürich & Newton, MA. |
2024-01-23 |
| Hephaistos-Pharma SAS. (1/23/24). "Press Release: Hephaistos-Pharma Secures a €2 Million Seed Round with Xista Science Ventures, Foundation Fournier-Majoie and Noshaq". Orsay. |
2024-01-23 |
| BioNTech SE. (1/22/24). "Press Release: BioNTech and DualityBio Initiate Pivotal Phase 3 Trial Of Antibody-Drug Conjugate Candidate BNT323/DB-1303 in Metastatic Breast Cancer". Mainz & Shanghai. |
2024-01-22 |
| CureVac N.V.. (1/17/24). "Press Release: CureVac CEO Alexander Zehnder Acquires Common Shares of Company Stock". Tübingen & Boston, MA. |
2024-01-17 |
| ITM Isotope Technologies Munich SE. (1/16/24). "Press Release: ITM Appoints Dr. Mark Harfensteller as Member of Its Executive Board". Garching. |
2024-01-16 |
| Stalicla S.A.. (1/16/24). "Press Release: Stalicla Secures $17.4 Million in Series B Financing to Propel Precision Neuro Advancements". Geneva. |
2024-01-16 |
| Disco Pharmaceuticals GmbH. (1/16/24). "Press Release: Disco Pharmaceuticals Launches as the Surfaceome Company with EUR 20 Million in Seed Financing". Cologne & Zurich. |
2024-01-16 |
| BIO Deutschland e. V.. (1/11/24). "Press Release: Biotech Industry. Financing Remains Stable – Turnaround on the Horizon". Berlin. |
2024-01-11 |
| WuXi Biologics. (1/11/24). "Press Release: WuXi Biologics Announces Research Service Agreement with BioNTech on Discovering Investigational Monoclonal Antibodies for Developing Next-Generation Therapeutic Product Candidates". Shanghai. |
2024-01-11 |
| Roche Deutschland Holding GmbH. (1/10/24). "Press Release: Prof. Hagen Pfundner wird zum 1. Mai 2024 Vorsitzender der Roche Deutschland Holding GmbH". |
2024-01-10 |
| Catalym GmbH. (1/9/24). "Press Release: Catalym Appoints Drug Development Leader Roy Baynes to its Board of Directors and Strengthens Scientific Advisory Board with Three Accomplished Lung and Bladder Cancer Specialists". Mainz. |
2024-01-09 |
| BioNTech SE. (1/9/24). "Press Release: BioNTech Outlines 2024 Strategic Priorities at the 42nd Annual J.P. Morgan Healthcare Conference". Mainz. |
2024-01-09 |
| Calypso Biotech B.V.. (1/8/24). "Press Release: Calypso Enters into Agreement to Be Acquired by Novartis". Amsterdam. |
2024-01-08 |
| Aion Labs. (1/8/24). "Press Release: Aion Labs Welcomes Amiti as Strategic Partner to Accelerate Israel's Position as a Leading Hub for Transformative AI-Powered Drug Discovery Innovation". Rehovot. |
2024-01-08 |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 6 7 8 ... 41 42 43 
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
